LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Molecular glue CELMoD compounds are regulators of cereblon conformation.

Watson, Edmond R / Novick, Scott / Matyskiela, Mary E / Chamberlain, Philip P / H de la Peña, Andres / Zhu, Jinyi / Tran, Eileen / Griffin, Patrick R / Wertz, Ingrid E / Lander, Gabriel C

Science (New York, N.Y.)

2022  Band 378, Heft 6619, Seite(n) 549–553

Abstract: Cereblon (CRBN) is a ubiquitin ligase (E3) substrate receptor protein co-opted by CRBN E3 ligase modulatory drug (CELMoD) agents that target therapeutically relevant proteins for degradation. Prior crystallographic studies defined the drug-binding site ... ...

Abstract Cereblon (CRBN) is a ubiquitin ligase (E3) substrate receptor protein co-opted by CRBN E3 ligase modulatory drug (CELMoD) agents that target therapeutically relevant proteins for degradation. Prior crystallographic studies defined the drug-binding site within CRBN's thalidomide-binding domain (TBD), but the allostery of drug-induced neosubstrate binding remains unclear. We performed cryo-electron microscopy analyses of the DNA damage-binding protein 1 (DDB1)-CRBN apo complex and compared these structures with DDB1-CRBN in the presence of CELMoD compounds alone and complexed with neosubstrates. Association of CELMoD compounds to the TBD is necessary and sufficient for triggering CRBN allosteric rearrangement from an open conformation to the canonical closed conformation. The neosubstrate Ikaros only stably associates with the closed CRBN conformation, illustrating the importance of allostery for CELMoD compound efficacy and informing structure-guided design strategies to improve therapeutic efficacy.
Mesh-Begriff(e) Adaptor Proteins, Signal Transducing/chemistry ; Cryoelectron Microscopy ; Thalidomide/chemistry ; Ubiquitin-Protein Ligases/chemistry ; Protein Domains ; Allosteric Regulation
Chemische Substanzen Adaptor Proteins, Signal Transducing ; CRBN protein, human ; Thalidomide (4Z8R6ORS6L) ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
Sprache Englisch
Erscheinungsdatum 2022-11-03
Erscheinungsland United States
Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
ZDB-ID 128410-1
ISSN 1095-9203 ; 0036-8075
ISSN (online) 1095-9203
ISSN 0036-8075
DOI 10.1126/science.add7574
Signatur
Zs.A 27: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MG 77: Hefte anzeigen
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang